An official website of the United States government
Opioids
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder: A pragmatic, multi-site, double-blind, Randomized, placebo-controlled, trial (TAB) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠
Adolescent outcomes of Post-operative opioid Exposure (APEX) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB)(NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠
Subthreshold Opioid Use Disorder Prevention (STOP) Trial (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
This study will test the efficacy of a primary care Subthreshold Opioid Use Disorder Prevention (STOP) intervention to reduce unhealthy opioid use and examine the impact of STOP on progression to moderate-severe OUD, overdose risk behavior, and overdose events in adults with unhealthy use of illicit/prescribed opioids.
NCT04218201
Jennifer McNeely, M.D., M.S.
Associate Professor
New York University Grossman School of Medicine
180 Madison Avenue, 17th Floor, New York, NY, 10016, US
Developing an Intervention to Address Intersecting Prescription Opioid and Chronic Pain Stigma in Cancer Survivors (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠
Investigators will conduct in-depth qualitative interviews exploring experiences with prescription opioid and chronic pain stigma among cancer survivors prescribed opioids for moderate-to-severe chronic pain and caregivers to identify potential contributors to stigma in cancer survivors, with an emphasis on potential targets of future interventions and long-term health outcomes associated with stigma in survivorship.
Hailey Bulls, Ph.D., M.A.
Assistance Professor of Medicine
University of Pittsburgh
Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®